Novavax Inc (XSWX:NVAX)
CHF 6.64 -0.090 (-1.34%) Market Cap: 1.09 Bil Enterprise Value: 691.72 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Novavax Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 12:30 AM GMT
Release Date Price: CHF6.48 (+0.78%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NVAX.OQ - Novavax Inc
Novavax Inc at JPMorgan Healthcare Conference
Jan 15, 2026 / 12:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, let's go ahead and get started. Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech analysts here at JP Morgan. I'm joined by my squad, Priyanka Grover, Joyces, and Rati Pinhei. Our next presenting company is Novavax and presenting on behalf of the company, we have CEO John Jacobs.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you.

Thanks everyone. Welcome and thanks for joining us to kick off 2026 at JPM. I'm John Jacobs, CEO of Novavax.

Before we get started, I just
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot